1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
PHS 2023 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications is sponsored by National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC). Supports small businesses in developing innovative technologies to improve public health, including digital health solutions for mental health.
Get alerted about grants like this
Get emailed when new opportunities from “National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Small businesses in the U.S. with fewer than 500 employees. Confirm the full requirements in the official notice before applying.
Applications for PHS 2023 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications are due September 5, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
PHS 2023 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications is funded by National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
PHS 2023 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Optional) is sponsored by National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC). This omnibus solicitation invites eligible United States small business concerns to submit Small Business Innovation Research (SBIR) grant applications for Phase I, Phase II, Direct to Phase II (NIH Only), Fast-Track (NIH only), and Phase IIB (NIH only) projects.
NIH Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Grant Opportunities is sponsored by National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC). These grant opportunities provide non-dilutive funding for early-stage biomedical and behavioral research and development with strong potential for commercialization. NCI, part of NIH, specifically includes in vitro and in vivo diagnostics (e.g., companion diagnostics and prognostic technologies) as areas of interest.
PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44]) (Clinical Trial Required) is sponsored by National Cancer Institute (NCI) of the National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC). This omnibus solicitation is for SBIR grant applications from small business concerns focusing on the commercial development of novel cancer-relevant technologies that require a clinical trial.
This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for funding to perform research leading to the development of innovative technologies that may advance progress for early detection and assessment of individuals at risk and for early diagnosis, prognosis and follow-up of type 1 diabetes (T1D). Funding Opportunity Number: RFA-DK-15-024. Assistance Listing: 93.847. Funding Instrument: G. Category: FN,HL. Award Amount: $2M total program funding.
This initiative will stimulate and support innovative research by small business concerns that may lead to the development of novel technologies for the early diagnosis, monitoring and treatment of micro and macro vascular complications of diabetes which are associated with significant morbidity and mortality of the disease and high costs to the health care system. Funding Opportunity Number: PA-14-058. Assistance Listing: 93.847. Funding Instrument: G. Category: FN,HL.
NIH has awarded 74% fewer new grants than its 2021-2024 average and is roughly $1 billion behind its normal timeline, but the FY2026 money still has to go out the door before the fiscal year ends. Here is why a year-end obligation cliff is coming, who is positioned to catch it, and how applicants should prepare for a compressed Q4 award rush.
Read articleNew NIH awards have fallen 34% in 2026, NSF is running months behind, and a proposed OMB rule would let political appointees terminate grants mid-stream. The funding environment for academic research has structurally changed. Here is a clear-eyed diversification strategy for PIs, research offices, and institutions that cannot wait for the political fight to resolve.
Read articleThe FY2026 COPS School Violence Prevention Program offers up to $500,000 per award across roughly 200 grants, with a 25% match and a $100,000 microgrant lane for rural and tribal schools. But the statute limits it to physical security and law enforcement coordination — not mental health. Here is what SVPP actually funds, who can apply, and how to build a competitive application before August 4, 2026.
Read article